Moelis (Moelis) Accounts Receivable : $50.0 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Moelis Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Moelis's accounts receivables for the quarter that ended in Mar. 2024 was $50.0 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Moelis's Days Sales Outstanding for the quarter that ended in Mar. 2024 was 20.97.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Moelis's Net-Net Working Capital per share for the quarter that ended in Mar. 2024 was $-7.22.

Moelis Accounts Receivable Historical Data

The historical data trend for Moelis's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moelis Accounts Receivable Chart

Moelis Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Receivable

Get a 7-Day Free Trial

45.07

89.30

41.87

47.83

51.22

Moelis Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Receivable	Get a 7-Day Free Trial															31.61	36.13	25.51	51.22	49.97

Moelis Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Moelis Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Moelis's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	49.97	/	217.485	*	91
=	20.97

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Moelis's accounts receivable are only considered to be worth 75% of book value:

Moelis's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2024 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(102.643	+	0.75 * 49.97	+	0.5 * 0	-	619.711
-	0	-	28.283)	/	70.3571
=	-7.22

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Moelis Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Moelis's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Moelis (Moelis) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » Moelis & Co (NYSE:MC) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

17M:Germany 17M:Germany

Address

399 Park Avenue, 4th Floor, New York, NY, USA, 10022

Website

https://www.moelis.com

Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.

Executives

Kenneth Moelis	director, 10 percent owner, officer: Chairman and CEO	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Ciafone Katherine Pilcher	officer: Chief Operating Officer	399 PARK AVE, NEW YORK NY 10022
Kenneth Shropshire	director	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10011
Elizabeth Crain	officer: Chief Operating Officer	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Navid Mahmoodzadegan	director, officer: Managing Director	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Osamu R. Watanabe	officer: General Counsel and Secretary	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Jeffrey Raich	director, officer: Managing Director	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Christopher Callesano	officer: SVP & Principal Acct Officer	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Laila Worrell	director	399 PARK AVENUE, NEW YORK NY 10022
Joseph Simon	officer: Chief Financial Officer	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
Yolonda C Richardson	director	399 PARK AVENUE, NEW YORK NY 10022
Leaman J Richard Iii	director, officer: Managing Partner	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022
John A Allison	director	PO BOX 1250, WINSTON SALEM NC 27102-1250
Yvonne Greenstreet	director	PACIRA PHARMACEUTICALS, INC., 5 SYLVAN WAY, PARSIPPANY NJ 07054
Eric Cantor	director	C/O MOELIS & COMPANY, 399 PARK AVENUE, 5TH FLOOR, NEW YORK NY 10022